Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program

dc.creatorGislaine Cândida Batista Jorge
dc.creatorAntônio Sérgio Barcala Jorge
dc.creatorMarise Fagundes Silveira
dc.creatorDeborah de Farias Lelis
dc.creatorJoão Marcus Oliveira Andrade
dc.creatorAlfredo Maurício Batista de Paula
dc.creatorAndré Luiz Sena Guimarães
dc.creatorSérgio Henrique Sousa Santos
dc.date.accessioned2022-09-06T14:48:28Z
dc.date.accessioned2025-09-09T00:44:12Z
dc.date.available2022-09-06T14:48:28Z
dc.date.issued2020-09
dc.description.sponsorshipCNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico
dc.description.sponsorshipFAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais
dc.description.sponsorshipCAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
dc.identifier.doihttps://doi.org/10.1016/j.lfs.2020.117962
dc.identifier.issn0024-3205
dc.identifier.urihttps://hdl.handle.net/1843/44954
dc.languageeng
dc.publisherUniversidade Federal de Minas Gerais
dc.relation.ispartofLife Sciences
dc.rightsAcesso Aberto
dc.subjectObesidade
dc.subjectSíndrome metabólica
dc.subjectDiabetes
dc.subjectTecido adiposo
dc.subjectPolifenóis
dc.subjectExercícios físicos
dc.subjectFitonutrientes
dc.titleOral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program
dc.typeArtigo de periódico
local.citation.spage117962
local.citation.volume256
local.description.resumoAims: the aim of the present study was to evaluate the oral resveratrol effects associated with diet and physical training changes on anthropometric and biochemical parameters. Main methods: 25 individuals aged from 30 to 60 years old; with Body Mass Index (BMI) ≥ 30 kg/m2 were included in the study. Following the primary evaluation (anthropometric and clinical), the patients were randomly divided into 2 groups: (1) Placebo: Physical activity program + Diet + Placebo; (2) Resveratrol: Physical activity program + Diet + Resveratrol (RVS) (250 mg/day) for three months. Anthropometric and biochemical parameters were evaluated at baseline and after the treatment period. Key findings: the main findings showed that the resveratrol supplementation improved total cholesterol (TC), High-density Lipoprotein cholesterol (HDL-c), Very-low density Lipoprotein cholesterol (VLDL-c), urea, creatinine and albumin serum levels. Significance: these findings indicate that this polyphenol may be an option to potentiate the beneficial effects induced by dietary and physical activity programs in the Metabolic Syndrome (MetS) treatment.
local.publisher.countryBrasil
local.publisher.departmentICA - INSTITUTO DE CIÊNCIAS AGRÁRIAS
local.publisher.initialsUFMG
local.url.externahttps://www.sciencedirect.com/science/article/pii/S0024320520307128?via%3Dihub#!

Arquivos

Pacote original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program.pdf
Tamanho:
1.01 MB
Formato:
Adobe Portable Document Format

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
License.txt
Tamanho:
1.99 KB
Formato:
Plain Text
Descrição: